Uncategorized
Anti-VEGF effect on development of macular atrophy under study
COPENHAGEN — A secondary analysis of data gathered in the IVAN trial looking at the question of whether anti-VEGFs cause macular atrophy yielded no definitive answer but did evoke more questions.“We’ve all seen patients in clinic who have had a good response in terms of fluid but have ended up with a reduction in visual acuity due to progression of macular atrophy,” Clare Bailey, MD, said at the Euretina meeting. The follow-on analysis of 596 eyes was undertaken to more precisely grade macular lesions with particular attention given to location (Read more...)